Structural Openings to Understand and Prevent Tick Borne Encephalitis
Acronym
2STOP_TBE
Description of the granted funding
Tick-borne encephalitis virus (TBEV) is emerging in Europe. It causes tick-borne encephalitis (TBE), a disease with a high mortality rate and even higher rates of life-long neurological effects in individuals that contract infections. As environmental and societal changes promote viral spread and current vaccine use is limited, it is not surprising that TBE incidence is on the rise. With uncertain diagnostics and no medications on the market, the threat to European health care becomes significant, making development of control measures a high priority.
Efforts to develop treatments and improve detection are largely hampered by a lack of structural knowledge about TBEV. Here we seek to fill the critical information gap, using electron cryo-microscopy, which has become a powerful technology for revealing atomic-level details about viruses. We will harness unique expertise in the fields of virology and structural biology to answer fundamental questions about virus structure, assembly, morphogenesis, and function. Explicit new knowledge regarding TBEV will push forward European excellence in virus research producing impactful results for their exploitation in drug discovery and diagnostic developments.
Show moreStarting year
2018
End year
2020
Granted funding
Amount granted
179 326 €
Funder
European Union
Funding instrument
Standard EF
Framework programme
Horizon 2020 Framework Programme
Call
Programme part
EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions (5220 Nurturing excellence by means of cross-border and cross-sector mobility (5222 )
Topic
Individual Fellowships (MSCA-IF-2017Call ID
H2020-MSCA-IF-2017 Other information
Funding decision number
799929
Identified topics
covid, pandemic, vaccines